Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApq Global Regulatory News (APQ)

  • There is currently no data for APQ

Trading Update

3 Apr 2024 07:00

RNS Number : 0063J
APQ Global Limited
03 April 2024
 

APQ Global Limited

 

("APQ Global" or the "Company")

 

Trading Update

 

APQ Global Limited, a company incorporated in Guernsey (company registration number 62008) which is listed on The International Stock Exchange and admitted to trading on AIM, today announces an update on trading for the period ended 31 December 2023 and 2024 year to date.

 

Highlights

· As announced on 22 March 2024, APQ's unaudited book value per Ordinary Share as at 29 February 2024 was 30.20 US Dollar cents (equivalent to 23.97 Pounds Sterling pence).

· This book value increase was substantially driven by the strong trading performance in APQ's direct investment in US-based capital raising and transaction advisory business Delphos International. This resulted in a significant increase in Delphos' independent third-party revaluation undertaken as part of APQ's 2023 financial year end audit process currently underway, from c.USD 6.3m at 31 December 2022 to c.USD 27.0m at 31 December 2023 (unaudited).

· Delphos International's trading highlights include:

Revenues increased by 145% between 2022 and 2023 calendar years

The business reached meaningful profitability for the first time in 2023

Current trading in 2024 continues to be strong, and its management team expects the business to exhibit further significant year on year growth in revenue and profits, with an attractive pipeline of transaction mandates under way

· The unaudited third-party valuation of APQ's investments in Parish Group and Delphos Canada also increased over the period to 31 December 2023, and the Board believes the outlook for these and APQ's other unlisted portfolio companies remains favourable for the remainder of 2024.

 

- End -

 

For further enquiries, please contact:

 

APQ Global Limited Bart Turtelboom

020 3478 9708

 

Singer Capital Markets - Nominated Adviser and Broker James Maxwell

020 7496 3000

Suntera - TISE sponsor Claire Torode

01481 737 277

Investor Relations

IR@APQGlobal.com

 

 

Notes to Editors

 

 

APQ Global Limited

 

APQ Global (ticker: APQ LN) is an investment company incorporated in Guernsey. The Company focuses its investment activities globally (in Asia, Latin America, Eastern Europe, the Middle East, Africa and the Channel Islands, particularly). The objective of the Company is to steadily grow its earnings to seek to deliver attractive returns and capital growth through a combination of building growing businesses as well as earning revenue from income generating operating activities in capital markets1. APQ Global run a well-diversified and liquid portfolio, take strategic stakes in selected businesses and plan to take operational control of companies through the acquisition of minority and majority stakes in companies with a focus on emerging markets. For more information, please visit apqglobal.com.

1 Where we refer to revenue from income generating operating activities this relates to the revenue of our investee companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSFFDEELSEDL
Date   Source Headline
25th Jan 20217:00 amRNSBook value report
13th Jan 20214:45 pmRNSIssue of Equity and PDMR – Correction Statement
12th Jan 20217:00 amRNSIssue of Equity and PDMR/Director Shareholding
15th Dec 20207:00 amRNSBook value report
26th Nov 20202:30 pmRNSHolding in City of London Investment Group plc
24th Nov 20204:15 pmRNSHolding(s) in Company
19th Nov 20205:54 pmRNSHolding(s) in Company
17th Nov 202010:00 amRNSBook Value Report
15th Oct 20207:00 amRNSBook value report
14th Oct 20201:30 pmRNSIssue of Equity and PDMR/Director Shareholding
14th Oct 20207:00 amRNSResult of AGM
18th Sep 20204:15 pmRNSNotice of AGM
18th Sep 20207:00 amRNSBook value report
15th Sep 20201:00 pmRNSInterim results for six months ending 30 June 2020
15th Sep 20201:00 pmRNSFinal results for the year to 31 December 2019
28th Aug 20207:00 amRNSUpdated Notice of Results
24th Aug 20207:00 amRNSBook value report
7th Aug 20207:00 amRNSIssue of Equity and PDMR/Director Shareholding
30th Jul 20202:00 pmRNSDelphos International appoints Noah Mamet
24th Jul 20207:00 amRNSNotice of Results
24th Jul 20207:00 amRNSBook value report
10th Jul 20202:00 pmRNSDelphos International appoints Mr. Kofi Appenteng
1st Jul 20207:00 amRNSChange of Articles relating to Conv Pref Shares
22nd Jun 20207:00 amRNSAnnual Report and Accounts
19th Jun 20207:00 amRNSBook value report
10th Jun 20207:00 amRNSChange of Company Secretary
9th Jun 20207:00 amRNSChange of Registered Office Address
20th May 20207:00 amRNSBook value report
20th May 20207:00 amRNSIssue of Equity and PDMR/Director Shareholding
6th Apr 20207:00 amRNSBook Value and Market Update
3rd Mar 20207:00 amRNSAcquisition of Delphos International, Ltd.
2nd Mar 202012:03 pmRNSHolding(s) in Company
19th Feb 20207:00 amRNSBook value report
29th Jan 20207:00 amRNSAcquisition, Warrant & Conv. Pref. Share Issue
28th Jan 20207:00 amRNSQuarterly Update
23rd Jan 20207:00 amRNSDividend Declaration
23rd Jan 20207:00 amRNSBook value report
16th Jan 20207:00 amRNSIssue of Equity and PDMR/Director Shareholding
17th Dec 20197:00 amRNSBook value report
18th Nov 20197:00 amRNSBook Value Announcement
12th Nov 201910:07 amRNSHolding(s) in Company
18th Oct 20197:01 amRNSIssue of Equity and PDMR/Director Shareholding
18th Oct 20197:00 amRNSQuarterly Update
18th Oct 20197:00 amRNSDividend Declaration
18th Oct 20197:00 amRNSBook value report
30th Sep 201912:00 pmRNSInterim results for period ending 30 June 2019
17th Sep 20197:00 amRNSBook value report
15th Aug 20197:00 amRNSBook value report
18th Jul 20197:00 amRNSQuarterly Update
18th Jul 20197:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.